Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy

MLA

Liu, Yuan-Yuan, et al. “Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy.” International Journal of General Medicine, vol. 15, Jan. 2022, pp. 123–31. EBSCOhost, https://doi.org/10.2147/ijgm.s337827.

APA

Liu, Y.-Y., Zhao, R.-F., Liu, C., Zhou, J., Yang, L., & Li, L. (2022). Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy. International Journal of General Medicine, 15, 123–131. https://doi.org/10.2147/ijgm.s337827

Chicago

Liu, Yuan-Yuan, Ren-Feng Zhao, Chao Liu, Jie Zhou, Liu Yang, and Li Li. 2022. “Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy.” International Journal of General Medicine 15 (January): 123–31. doi:10.2147/ijgm.s337827.